» Articles » PMID: 33553428

Effects of Implant Surface Debridement and Systemic Antibiotics on the Clinical and Microbiological Variables of Periimplantitis

Overview
Journal Biomed Res Int
Publisher Wiley
Date 2021 Feb 8
PMID 33553428
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To investigate the role of implant surface debridement alone and in conjunction with systemic antibiotics on the clinical and microbiological variables of periimplantitis.

Materials And Methods: Data of forty-six patients with at least one dental implant having bleeding-on-probing (BoP), probing pocket depth (PPD) of more than 5 mm, and radiographic bone loss of more than 3 mm were retrieved from clinical records. Data was recorded for dental implant with the deepest PPD, BoP, and bone loss from each patient. "Group-A" received implant surface debridement alone, while "group-B" additionally received systemic antibiotics. Clinical and microbiological data of patients were compared before and after the treatment.

Results: At the implant level, a significant reduction of PPD, mucosal recession (MR), and BoP was achieved for all patients. Group B achieved significant improvement in MR and BoP compared to group A at implant level. PPD, MR, and plaque scores showed improvement at implant site level. At 3 months recall visit, 44% of group A and 52% of group B implants required surgical treatment. The presence and proportions of studied bacteria of both groups did not differ significantly at the recall visit when compared to the initial visit. However, P. intermedia and P. micros showed a significant reduction in group A at the recall visit.

Conclusions: Implant surface debridement improved the clinical parameters of periimplantitis. In addition, adjunctive use of systemic antibiotics increased mucosal recession and improved bleeding on probing in periimplantitis.

Citing Articles

[Rehabilitation of a case with active periodontitis and advanced perii-implantitis. Minimally invasive approach].

Anitua E Rev Cient Odontol (Lima). 2024; 10(2):e113.

PMID: 39678187 PMC: 11641415. DOI: 10.21142/2523-2754-1002-2022-113.


A Systematic Review and Meta-Analysis of Systemic Antibiotic Therapy in the Treatment of Peri-Implantitis.

Toledano-Osorio M, Vallecillo C, Toledano R, Aguilera F, Osorio M, Munoz-Soto E Int J Environ Res Public Health. 2022; 19(11).

PMID: 35682086 PMC: 9180155. DOI: 10.3390/ijerph19116502.


Peri-Implantitis: Application of a Protocol for the Regeneration of Deep Osseous Defects. A Retrospective Case Series.

Verardi S, Valente N Int J Environ Res Public Health. 2021; 18(23).

PMID: 34886384 PMC: 8656633. DOI: 10.3390/ijerph182312658.


Methods of Topical Administration of Drugs and Biological Active Substances for Dental Implants-A Narrative Review.

Wychowanski P, Starzynska A, Adamska P, Slupecka-Ziemilska M, Sobocki B, Chmielewska A Antibiotics (Basel). 2021; 10(8).

PMID: 34438969 PMC: 8388631. DOI: 10.3390/antibiotics10080919.

References
1.
Winkel E, van Winkelhoff A, Van der Velden U . Additional clinical and microbiological effects of amoxicillin and metronidazole after initial periodontal therapy. J Clin Periodontol. 1998; 25(11 Pt 1):857-64. DOI: 10.1111/j.1600-051x.1998.tb02382.x. View

2.
Rams T, ROBERTS T, Feik D, Molzan A, Slots J . Clinical and microbiological findings on newly inserted hydroxyapatite-coated and pure titanium human dental implants. Clin Oral Implants Res. 1991; 2(3):121-7. DOI: 10.1034/j.1600-0501.1991.020304.x. View

3.
Becker W, Becker B, Newman M, Nyman S . Clinical and microbiologic findings that may contribute to dental implant failure. Int J Oral Maxillofac Implants. 1990; 5(1):31-8. View

4.
Heitz-Mayfield L . Diagnosis and management of peri-implant diseases. Aust Dent J. 2008; 53 Suppl 1:S43-8. DOI: 10.1111/j.1834-7819.2008.00041.x. View

5.
de Jong K, Oosting J, Abraham-Inpijn L . Medical risk classification of dental patients in The Netherlands. J Public Health Dent. 1993; 53(4):219-22. DOI: 10.1111/j.1752-7325.1993.tb02707.x. View